BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 32536039)

  • 1. Proteomic analysis enables distinction of early- versus advanced-stage lung adenocarcinomas.
    Kelemen O; Pla I; Sanchez A; Rezeli M; Szasz AM; Malm J; Laszlo V; Kwon HJ; Dome B; Marko-Varga G
    Clin Transl Med; 2020 Jun; 10(2):e106. PubMed ID: 32536039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma.
    Liu YF; Xiao ZQ; Li MX; Li MY; Zhang PF; Li C; Li F; Chen YH; Yi H; Yao HX; Chen ZC
    J Pathol; 2009 Jan; 217(1):54-64. PubMed ID: 18798225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of integrin β1 as a prognostic biomarker for human lung adenocarcinoma using 2D-LC-MS/MS combined with iTRAQ technology.
    Zhang PF; Zeng GQ; Yi LZ; Liu JP; Wan XX; Qu JQ; Li JH; Li C; Tang CE; Hu R; Ye X; Chen Y; Chen ZC; Xiao ZQ
    Oncol Rep; 2013 Jul; 30(1):341-9. PubMed ID: 23677397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics.
    Yang S; Chen L; Chan DW; Li QK; Zhang H
    Clin Proteomics; 2017; 14():31. PubMed ID: 28814946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of flotillin-1 as a novel biomarker for lymph node metastasis and prognosis of lung adenocarcinoma by quantitative plasma membrane proteome analysis.
    Zhang PF; Zeng GQ; Hu R; Li C; Yi H; Li MY; Li XH; Qu JQ; Wan XX; He QY; Li JH; Chen Y; Ye X; Li JY; Wang YY; Feng XP; Xiao ZQ
    J Proteomics; 2012 Dec; 77():202-14. PubMed ID: 22982323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Proteomic Features To Distinguish Benign Pulmonary Nodules from Lung Adenocarcinoma.
    Codreanu SG; Hoeksema MD; Slebos RJC; Zimmerman LJ; Rahman SMJ; Li M; Chen SC; Chen H; Eisenberg R; Liebler DC; Massion PP
    J Proteome Res; 2017 Sep; 16(9):3266-3276. PubMed ID: 28731711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomics analysis of mitochondrial proteins in lung adenocarcinomas and normal lung tissue using iTRAQ and tandem mass spectrometry.
    Li W; Zhang X; Wang W; Sun R; Liu B; Ma Y; Zhang W; Ma L; Jin Y; Yang S
    Am J Transl Res; 2017; 9(9):3918-3934. PubMed ID: 28979670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteomic profiling of laser-microdissected lung adenocarcinoma cells of early lepidic-types.
    Kato Y; Nakamura H; Tojo H; Nomura M; Nagao T; Kawamura T; Kodama T; Ohira T; Ikeda N; Fehniger T; Marko-Varga G; Nishimura T; Kato H
    Clin Transl Med; 2015 Dec; 4(1):64. PubMed ID: 26162278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 90-β over-expression is associated with poor survival in stage I lung adenocarcinoma patients.
    Wu Y; Huang B; Liu Q; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8252-9. PubMed ID: 26339394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Multicenter Study Investigating the Role of Targeted Next-Generation Sequencing of Selected Cancer Genes in Mucinous Adenocarcinoma of the Lung.
    Righi L; Vatrano S; Di Nicolantonio F; Massa F; Rossi G; Cavazza A; Volante M; Votta A; Izzo S; Lo Iacono M; Ardissone F; Di Maio M; Novello S; Scagliotti GV; Papotti M
    J Thorac Oncol; 2016 Apr; 11(4):504-15. PubMed ID: 26774193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumican is overexpressed in lung adenocarcinoma pleural effusions.
    Cappellesso R; Millioni R; Arrigoni G; Simonato F; Caroccia B; Iori E; Guzzardo V; Ventura L; Tessari P; Fassina A
    PLoS One; 2015; 10(5):e0126458. PubMed ID: 25961303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of the novel IASLC/ATS/ERS classification of lung adenocarcinoma in advanced disease.
    Campos-Parra AD; Avilés A; Contreras-Reyes S; Rojas-Marín CE; Sánchez-Reyes R; Borbolla-Escoboza RJ; Arrieta O
    Eur Respir J; 2014 May; 43(5):1439-47. PubMed ID: 24435003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
    An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
    Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
    Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
    Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC amplification as a prognostic marker of early-stage lung adenocarcinoma identified by whole genome copy number analysis.
    Iwakawa R; Kohno T; Kato M; Shiraishi K; Tsuta K; Noguchi M; Ogawa S; Yokota J
    Clin Cancer Res; 2011 Mar; 17(6):1481-9. PubMed ID: 21148746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of proteins expressed differently among surgically resected stage I lung adenocarcinomas.
    Ha ES; Choi S; In KH; Lee SH; Lee EJ; Lee SY; Kim JH; Shin C; Shim JJ; Kang KH; Phark S; Sul D
    Clin Biochem; 2013 Mar; 46(4-5):369-77. PubMed ID: 23200884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD63 as a biomarker for predicting the clinical outcomes in adenocarcinoma of lung.
    Kwon MS; Shin SH; Yim SH; Lee KY; Kang HM; Kim TM; Chung YJ
    Lung Cancer; 2007 Jul; 57(1):46-53. PubMed ID: 17350713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anterior gradient 2 overexpression in lung adenocarcinoma.
    Pizzi M; Fassan M; Balistreri M; Galligioni A; Rea F; Rugge M
    Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):31-6. PubMed ID: 21768879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Spread through Air Spaces Affects the Recurrence and Overall Survival in Patients with Lung Adenocarcinoma >2 to 3 cm.
    Dai C; Xie H; Su H; She Y; Zhu E; Fan Z; Zhou F; Ren Y; Xie D; Zheng H; Kadeer X; Chen D; Zhang L; Jiang G; Wu C; Chen C
    J Thorac Oncol; 2017 Jul; 12(7):1052-1060. PubMed ID: 28389373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
    Song YH; Zhang CQ; Chen FF; Lin XY
    Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.